PubMed:18509108 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycan-Motif

    {"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":88,"end":91},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T2","span":{"begin":88,"end":91},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T3","span":{"begin":92,"end":95},"obj":"https://glytoucan.org/Structures/Glycans/G33570YF"},{"id":"T4","span":{"begin":92,"end":95},"obj":"https://glytoucan.org/Structures/Glycans/G93899SO"},{"id":"T5","span":{"begin":122,"end":125},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T6","span":{"begin":122,"end":125},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T7","span":{"begin":351,"end":354},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T8","span":{"begin":351,"end":354},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T9","span":{"begin":413,"end":416},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T10","span":{"begin":413,"end":416},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T11","span":{"begin":485,"end":508},"obj":"https://glytoucan.org/Structures/Glycans/G50850NI"},{"id":"T12","span":{"begin":485,"end":508},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T13","span":{"begin":510,"end":516},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T14","span":{"begin":555,"end":561},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T15","span":{"begin":577,"end":586},"obj":"https://glytoucan.org/Structures/Glycans/G65889KE"},{"id":"T16","span":{"begin":577,"end":586},"obj":"https://glytoucan.org/Structures/Glycans/G68158BT"},{"id":"T17","span":{"begin":616,"end":622},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T18","span":{"begin":1272,"end":1275},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T19","span":{"begin":1272,"end":1275},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T20","span":{"begin":1281,"end":1284},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T21","span":{"begin":1281,"end":1284},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T22","span":{"begin":1377,"end":1380},"obj":"https://glytoucan.org/Structures/Glycans/G33570YF"},{"id":"T23","span":{"begin":1377,"end":1380},"obj":"https://glytoucan.org/Structures/Glycans/G93899SO"},{"id":"T24","span":{"begin":1437,"end":1440},"obj":"https://glytoucan.org/Structures/Glycans/G33570YF"},{"id":"T25","span":{"begin":1437,"end":1440},"obj":"https://glytoucan.org/Structures/Glycans/G93899SO"},{"id":"T26","span":{"begin":1490,"end":1493},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T27","span":{"begin":1490,"end":1493},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T28","span":{"begin":1601,"end":1604},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T29","span":{"begin":1601,"end":1604},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T30","span":{"begin":1657,"end":1660},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T31","span":{"begin":1657,"end":1660},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T32","span":{"begin":1736,"end":1747},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T33","span":{"begin":1755,"end":1758},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T34","span":{"begin":1755,"end":1758},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T35","span":{"begin":1790,"end":1793},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T36","span":{"begin":1790,"end":1793},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T37","span":{"begin":1896,"end":1899},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T38","span":{"begin":1896,"end":1899},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T39","span":{"begin":2005,"end":2017},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T40","span":{"begin":2057,"end":2060},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T41","span":{"begin":2057,"end":2060},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T42","span":{"begin":2142,"end":2153},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos6-Glycan-Motif-Image

    {"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":88,"end":91},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":92,"end":95},"obj":"Glycan_Motif"},{"id":"T5","span":{"begin":122,"end":125},"obj":"Glycan_Motif"},{"id":"T7","span":{"begin":351,"end":354},"obj":"Glycan_Motif"},{"id":"T9","span":{"begin":413,"end":416},"obj":"Glycan_Motif"},{"id":"T11","span":{"begin":485,"end":508},"obj":"Glycan_Motif"},{"id":"T13","span":{"begin":510,"end":516},"obj":"Glycan_Motif"},{"id":"T14","span":{"begin":555,"end":561},"obj":"Glycan_Motif"},{"id":"T15","span":{"begin":577,"end":586},"obj":"Glycan_Motif"},{"id":"T17","span":{"begin":616,"end":622},"obj":"Glycan_Motif"},{"id":"T18","span":{"begin":1272,"end":1275},"obj":"Glycan_Motif"},{"id":"T20","span":{"begin":1281,"end":1284},"obj":"Glycan_Motif"},{"id":"T22","span":{"begin":1377,"end":1380},"obj":"Glycan_Motif"},{"id":"T24","span":{"begin":1437,"end":1440},"obj":"Glycan_Motif"},{"id":"T26","span":{"begin":1490,"end":1493},"obj":"Glycan_Motif"},{"id":"T28","span":{"begin":1601,"end":1604},"obj":"Glycan_Motif"},{"id":"T30","span":{"begin":1657,"end":1660},"obj":"Glycan_Motif"},{"id":"T32","span":{"begin":1736,"end":1747},"obj":"Glycan_Motif"},{"id":"T33","span":{"begin":1755,"end":1758},"obj":"Glycan_Motif"},{"id":"T35","span":{"begin":1790,"end":1793},"obj":"Glycan_Motif"},{"id":"T37","span":{"begin":1896,"end":1899},"obj":"Glycan_Motif"},{"id":"T39","span":{"begin":2005,"end":2017},"obj":"Glycan_Motif"},{"id":"T40","span":{"begin":2057,"end":2060},"obj":"Glycan_Motif"},{"id":"T42","span":{"begin":2142,"end":2153},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G93899SO"},{"id":"A4","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G33570YF"},{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A6","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A7","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK"},{"id":"A8","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH"},{"id":"A9","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A10","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A11","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A12","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G50850NI"},{"id":"A13","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A14","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A15","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G68158BT"},{"id":"A16","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G65889KE"},{"id":"A17","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A18","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK"},{"id":"A19","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH"},{"id":"A20","pred":"image","subj":"T20","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A21","pred":"image","subj":"T20","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A22","pred":"image","subj":"T22","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G93899SO"},{"id":"A23","pred":"image","subj":"T22","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G33570YF"},{"id":"A24","pred":"image","subj":"T24","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G93899SO"},{"id":"A25","pred":"image","subj":"T24","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G33570YF"},{"id":"A26","pred":"image","subj":"T26","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A27","pred":"image","subj":"T26","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A28","pred":"image","subj":"T28","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A29","pred":"image","subj":"T28","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A30","pred":"image","subj":"T30","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A31","pred":"image","subj":"T30","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A32","pred":"image","subj":"T32","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A33","pred":"image","subj":"T33","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A34","pred":"image","subj":"T33","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A35","pred":"image","subj":"T35","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK"},{"id":"A36","pred":"image","subj":"T35","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH"},{"id":"A37","pred":"image","subj":"T37","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A38","pred":"image","subj":"T37","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A39","pred":"image","subj":"T39","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A40","pred":"image","subj":"T40","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A41","pred":"image","subj":"T40","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A42","pred":"image","subj":"T42","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    PMID_GLOBAL

    {"project":"PMID_GLOBAL","denotations":[{"id":"T1","span":{"begin":678,"end":680},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":702,"end":704},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":743,"end":745},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0009691"},{"id":"A2","pred":"mondo_id","subj":"T1","obj":"0020481"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0008091"},{"id":"A4","pred":"mondo_id","subj":"T3","obj":"0011603"},{"id":"A5","pred":"mondo_id","subj":"T3","obj":"0018958"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0020320"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":953,"end":965},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":966,"end":979},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1832,"end":2154},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"T6","span":{"begin":953,"end":979},"obj":"Sentence"},{"id":"T7","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"T8","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"T9","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"T10","span":{"begin":1832,"end":2154},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"T6","span":{"begin":953,"end":965},"obj":"Sentence"},{"id":"T7","span":{"begin":966,"end":979},"obj":"Sentence"},{"id":"T8","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"T9","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"T10","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"T11","span":{"begin":1832,"end":2154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos6-Glycan-Motif-Structure

    {"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":88,"end":91},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T2","span":{"begin":88,"end":91},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T3","span":{"begin":92,"end":95},"obj":"https://glytoucan.org/Structures/Glycans/G33570YF"},{"id":"T4","span":{"begin":92,"end":95},"obj":"https://glytoucan.org/Structures/Glycans/G93899SO"},{"id":"T5","span":{"begin":122,"end":125},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T6","span":{"begin":122,"end":125},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T7","span":{"begin":351,"end":354},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T8","span":{"begin":351,"end":354},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T9","span":{"begin":413,"end":416},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T10","span":{"begin":413,"end":416},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T11","span":{"begin":485,"end":508},"obj":"https://glytoucan.org/Structures/Glycans/G50850NI"},{"id":"T12","span":{"begin":485,"end":508},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T13","span":{"begin":510,"end":516},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T14","span":{"begin":555,"end":561},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T15","span":{"begin":577,"end":586},"obj":"https://glytoucan.org/Structures/Glycans/G65889KE"},{"id":"T16","span":{"begin":577,"end":586},"obj":"https://glytoucan.org/Structures/Glycans/G68158BT"},{"id":"T17","span":{"begin":616,"end":622},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T18","span":{"begin":1272,"end":1275},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T19","span":{"begin":1272,"end":1275},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T20","span":{"begin":1281,"end":1284},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T21","span":{"begin":1281,"end":1284},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T22","span":{"begin":1377,"end":1380},"obj":"https://glytoucan.org/Structures/Glycans/G33570YF"},{"id":"T23","span":{"begin":1377,"end":1380},"obj":"https://glytoucan.org/Structures/Glycans/G93899SO"},{"id":"T24","span":{"begin":1437,"end":1440},"obj":"https://glytoucan.org/Structures/Glycans/G33570YF"},{"id":"T25","span":{"begin":1437,"end":1440},"obj":"https://glytoucan.org/Structures/Glycans/G93899SO"},{"id":"T26","span":{"begin":1490,"end":1493},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T27","span":{"begin":1490,"end":1493},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T28","span":{"begin":1601,"end":1604},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T29","span":{"begin":1601,"end":1604},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T30","span":{"begin":1657,"end":1660},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T31","span":{"begin":1657,"end":1660},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T32","span":{"begin":1736,"end":1747},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T33","span":{"begin":1755,"end":1758},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T34","span":{"begin":1755,"end":1758},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T35","span":{"begin":1790,"end":1793},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T36","span":{"begin":1790,"end":1793},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T37","span":{"begin":1896,"end":1899},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T38","span":{"begin":1896,"end":1899},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T39","span":{"begin":2005,"end":2017},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T40","span":{"begin":2057,"end":2060},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T41","span":{"begin":2057,"end":2060},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T42","span":{"begin":2142,"end":2153},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    Glycosmos6-GlycoEpitope

    {"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":92,"end":95},"obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"T2","span":{"begin":1377,"end":1380},"obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"T3","span":{"begin":1437,"end":1440},"obj":"http://www.glycoepitope.jp/epitopes/EP0070"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlycoBiology-GDGDB

    {"project":"GlycoBiology-GDGDB","denotations":[{"id":"_T1","span":{"begin":702,"end":704},"obj":"http://acgg.asia/db/diseases/gdgdb?con_ui=CON00386"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlycoBiology-PACDB

    {"project":"GlycoBiology-PACDB","denotations":[{"id":"_T1","span":{"begin":22,"end":42},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC257,LEC564"},{"id":"_T2","span":{"begin":206,"end":226},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC257,LEC564"},{"id":"_T3","span":{"begin":856,"end":876},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC257,LEC564"},{"id":"_T4","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC243,LEC640"},{"id":"_T5","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC157,LEC407"},{"id":"_T6","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC754"},{"id":"_T7","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC002,LEC056,LEC062,LEC069,LEC081,LEC111,LEC133,LEC171,LEC177,LEC187,LEC211,LEC242,LEC252,LEC258,LEC259,LEC260,LEC262,LEC369,LEC377,LEC422,LEC442,LEC448,LEC450,LEC451,LEC454,LEC472,LEC492,LEC620"},{"id":"_T8","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC295,LEC417"},{"id":"_T9","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC487"},{"id":"_T10","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC244,LEC256,LEC354"},{"id":"_T11","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC054,LEC058,LEC073,LEC082,LEC091,LEC103,LEC109,LEC110,LEC123,LEC158,LEC179,LEC198,LEC205,LEC222,LEC223,LEC224,LEC225,LEC232,LEC298,LEC357,LEC378,LEC383,LEC388,LEC389,LEC397,LEC401,LEC410,LEC452"},{"id":"_T12","span":{"begin":1128,"end":1144},"obj":"http://acgg.asia/db/diseases/pacdb/lec?ids=LEC636"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":485,"end":508},"obj":"http://www.uniprot.org/uniprot/Q9BXD5"},{"id":"T2","span":{"begin":485,"end":508},"obj":"http://www.uniprot.org/uniprot/Q9NR45"},{"id":"T3","span":{"begin":550,"end":553},"obj":"http://www.uniprot.org/uniprot/P21941"},{"id":"T4","span":{"begin":1991,"end":1994},"obj":"http://www.uniprot.org/uniprot/P21941"},{"id":"T5","span":{"begin":743,"end":745},"obj":"http://www.uniprot.org/uniprot/P35318"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    uniprot-mouse

    {"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":743,"end":745},"obj":"http://www.uniprot.org/uniprot/P97297"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlycoBiology-NCBITAXON

    {"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":22,"end":42},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/197"},{"id":"T2","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538108"},{"id":"T3","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538076"},{"id":"T4","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538084"},{"id":"T5","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538085"},{"id":"T6","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538091"},{"id":"T7","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538097"},{"id":"T8","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538099"},{"id":"T9","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538101"},{"id":"T10","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538104"},{"id":"T11","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/1368069"},{"id":"T12","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538107"},{"id":"T13","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538075"},{"id":"T14","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538113"},{"id":"T15","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538117"},{"id":"T16","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/1730"},{"id":"T17","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/138290"},{"id":"T18","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/336403"},{"id":"T19","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/336404"},{"id":"T20","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/1144558"},{"id":"T21","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/336405"},{"id":"T22","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/674166"},{"id":"T23","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/400048"},{"id":"T24","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/538072"},{"id":"T25","span":{"begin":196,"end":205},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/336400"},{"id":"T26","span":{"begin":206,"end":226},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/197"},{"id":"T27","span":{"begin":658,"end":665},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/655550"},{"id":"T28","span":{"begin":856,"end":876},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/197"},{"id":"T29","span":{"begin":1100,"end":1106},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/722432"},{"id":"T30","span":{"begin":1100,"end":1106},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/79338"},{"id":"T31","span":{"begin":1128,"end":1139},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/561"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":157,"end":183},"obj":"http://purl.obolibrary.org/obo/GO_0052798"},{"id":"T2","span":{"begin":1677,"end":1702},"obj":"http://purl.obolibrary.org/obo/GO_0052798"},{"id":"T3","span":{"begin":163,"end":183},"obj":"http://purl.obolibrary.org/obo/GO_0004308"},{"id":"T4","span":{"begin":1510,"end":1529},"obj":"http://purl.obolibrary.org/obo/GO_0004308"},{"id":"T5","span":{"begin":1683,"end":1702},"obj":"http://purl.obolibrary.org/obo/GO_0004308"},{"id":"T6","span":{"begin":433,"end":453},"obj":"http://purl.obolibrary.org/obo/GO_0004517"},{"id":"T7","span":{"begin":1397,"end":1415},"obj":"http://purl.obolibrary.org/obo/GO_0004517"},{"id":"T8","span":{"begin":1916,"end":1933},"obj":"http://purl.obolibrary.org/obo/GO_0004517"},{"id":"T9","span":{"begin":878,"end":890},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T10","span":{"begin":894,"end":904},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T11","span":{"begin":1583,"end":1589},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T12","span":{"begin":1206,"end":1234},"obj":"http://purl.obolibrary.org/obo/GO_0008373"},{"id":"T13","span":{"begin":1259,"end":1268},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T14","span":{"begin":1424,"end":1433},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T15","span":{"begin":2044,"end":2053},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T16","span":{"begin":1991,"end":2011},"obj":"http://purl.obolibrary.org/obo/GO_0008781"},{"id":"T17","span":{"begin":1991,"end":2017},"obj":"http://purl.obolibrary.org/obo/GO_0008781"},{"id":"T18","span":{"begin":1991,"end":2017},"obj":"http://purl.obolibrary.org/obo/GO_0047392"},{"id":"T19","span":{"begin":1995,"end":2017},"obj":"http://purl.obolibrary.org/obo/GO_0008747"},{"id":"T20","span":{"begin":1995,"end":2017},"obj":"http://purl.obolibrary.org/obo/GO_0015538"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":931,"end":935},"obj":"http://purl.obolibrary.org/obo/GO_0019013"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlycoBiology-MAT

    {"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":196,"end":205},"obj":"http://purl.obolibrary.org/obo/MAT_0000191"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyTouCan-IUPAC

    {"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T2","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T3","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T4","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T5","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T6","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T7","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T8","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T9","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T10","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T11","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T12","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T13","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T14","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T15","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T16","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T17","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T18","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T19","span":{"begin":510,"end":516},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T20","span":{"begin":555,"end":561},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T21","span":{"begin":616,"end":622},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlycoBiology-Epitope

    {"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T1","span":{"begin":92,"end":95},"obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"PD-GlycoEpitope-B_T2","span":{"begin":1377,"end":1380},"obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"PD-GlycoEpitope-B_T3","span":{"begin":1437,"end":1440},"obj":"http://www.glycoepitope.jp/epitopes/EP0070"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    Glycan-GlyCosmos

    {"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":88,"end":91},"obj":"Glycan"},{"id":"T2","span":{"begin":92,"end":95},"obj":"Glycan"},{"id":"T3","span":{"begin":122,"end":125},"obj":"Glycan"},{"id":"T4","span":{"begin":351,"end":354},"obj":"Glycan"},{"id":"T5","span":{"begin":413,"end":416},"obj":"Glycan"},{"id":"T6","span":{"begin":510,"end":516},"obj":"Glycan"},{"id":"T7","span":{"begin":555,"end":561},"obj":"Glycan"},{"id":"T8","span":{"begin":590,"end":597},"obj":"Glycan"},{"id":"T9","span":{"begin":616,"end":622},"obj":"Glycan"},{"id":"T10","span":{"begin":1272,"end":1275},"obj":"Glycan"},{"id":"T11","span":{"begin":1281,"end":1284},"obj":"Glycan"},{"id":"T12","span":{"begin":1377,"end":1380},"obj":"Glycan"},{"id":"T13","span":{"begin":1437,"end":1440},"obj":"Glycan"},{"id":"T14","span":{"begin":1490,"end":1493},"obj":"Glycan"},{"id":"T15","span":{"begin":1601,"end":1604},"obj":"Glycan"},{"id":"T16","span":{"begin":1657,"end":1660},"obj":"Glycan"},{"id":"T17","span":{"begin":1755,"end":1758},"obj":"Glycan"},{"id":"T18","span":{"begin":1790,"end":1793},"obj":"Glycan"},{"id":"T19","span":{"begin":1896,"end":1899},"obj":"Glycan"},{"id":"T20","span":{"begin":2057,"end":2060},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A21","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G93899SO"},{"id":"A22","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G93899SO"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A23","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A24","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A25","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A6","pred":"glycosmos_id","subj":"T6","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A26","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A27","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A8","pred":"glycosmos_id","subj":"T8","obj":"https://glycosmos.org/glycans/show/G15541SE"},{"id":"A28","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G15541SE"},{"id":"A9","pred":"glycosmos_id","subj":"T9","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A29","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A10","pred":"glycosmos_id","subj":"T10","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A30","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A31","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G93899SO"},{"id":"A32","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G93899SO"},{"id":"A13","pred":"glycosmos_id","subj":"T13","obj":"https://glycosmos.org/glycans/show/G93899SO"},{"id":"A33","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G93899SO"},{"id":"A14","pred":"glycosmos_id","subj":"T14","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A34","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A15","pred":"glycosmos_id","subj":"T15","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A35","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A16","pred":"glycosmos_id","subj":"T16","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A36","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A17","pred":"glycosmos_id","subj":"T17","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A37","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A18","pred":"glycosmos_id","subj":"T18","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A38","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A19","pred":"glycosmos_id","subj":"T19","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A39","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A20","pred":"glycosmos_id","subj":"T20","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A40","pred":"image","subj":"T20","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos-GlycoEpitope

    {"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":92,"end":95},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":1377,"end":1380},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":1437,"end":1440},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0070"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos15-NCBITAXON

    {"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T1","span":{"begin":22,"end":42},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":206,"end":226},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":856,"end":876},"obj":"OrganismTaxon"},{"id":"T4","span":{"begin":1128,"end":1144},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"197"},{"id":"A2","pred":"db_id","subj":"T2","obj":"197"},{"id":"A3","pred":"db_id","subj":"T3","obj":"197"},{"id":"A4","pred":"db_id","subj":"T4","obj":"562"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":953,"end":965},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":966,"end":979},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1832,"end":2154},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"T6","span":{"begin":953,"end":979},"obj":"Sentence"},{"id":"T7","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"T8","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"T9","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"T10","span":{"begin":1832,"end":2154},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"T6","span":{"begin":953,"end":965},"obj":"Sentence"},{"id":"T7","span":{"begin":966,"end":979},"obj":"Sentence"},{"id":"T8","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"T9","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"T10","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"T11","span":{"begin":1832,"end":2154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":184},"obj":"Sentence"},{"id":"T2","span":{"begin":185,"end":760},"obj":"Sentence"},{"id":"T3","span":{"begin":761,"end":766},"obj":"Sentence"},{"id":"T4","span":{"begin":767,"end":877},"obj":"Sentence"},{"id":"T5","span":{"begin":878,"end":952},"obj":"Sentence"},{"id":"T6","span":{"begin":953,"end":979},"obj":"Sentence"},{"id":"T7","span":{"begin":980,"end":1163},"obj":"Sentence"},{"id":"T8","span":{"begin":1164,"end":1457},"obj":"Sentence"},{"id":"T9","span":{"begin":1458,"end":1831},"obj":"Sentence"},{"id":"T10","span":{"begin":1832,"end":2154},"obj":"Sentence"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos15-Glycan

    {"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":88,"end":91},"obj":"Glycan"},{"id":"T2","span":{"begin":92,"end":95},"obj":"Glycan"},{"id":"T3","span":{"begin":122,"end":125},"obj":"Glycan"},{"id":"T4","span":{"begin":351,"end":354},"obj":"Glycan"},{"id":"T5","span":{"begin":413,"end":416},"obj":"Glycan"},{"id":"T6","span":{"begin":510,"end":516},"obj":"Glycan"},{"id":"T7","span":{"begin":555,"end":561},"obj":"Glycan"},{"id":"T8","span":{"begin":590,"end":597},"obj":"Glycan"},{"id":"T9","span":{"begin":616,"end":622},"obj":"Glycan"},{"id":"T10","span":{"begin":1272,"end":1275},"obj":"Glycan"},{"id":"T11","span":{"begin":1281,"end":1284},"obj":"Glycan"},{"id":"T12","span":{"begin":1377,"end":1380},"obj":"Glycan"},{"id":"T13","span":{"begin":1437,"end":1440},"obj":"Glycan"},{"id":"T14","span":{"begin":1490,"end":1493},"obj":"Glycan"},{"id":"T15","span":{"begin":1601,"end":1604},"obj":"Glycan"},{"id":"T16","span":{"begin":1657,"end":1660},"obj":"Glycan"},{"id":"T17","span":{"begin":1755,"end":1758},"obj":"Glycan"},{"id":"T18","span":{"begin":1790,"end":1793},"obj":"Glycan"},{"id":"T19","span":{"begin":1896,"end":1899},"obj":"Glycan"},{"id":"T20","span":{"begin":2057,"end":2060},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G93899SO"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A6","pred":"glycosmos_id","subj":"T6","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A8","pred":"glycosmos_id","subj":"T8","obj":"https://glycosmos.org/glycans/show/G15541SE"},{"id":"A9","pred":"glycosmos_id","subj":"T9","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A10","pred":"glycosmos_id","subj":"T10","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G93899SO"},{"id":"A13","pred":"glycosmos_id","subj":"T13","obj":"https://glycosmos.org/glycans/show/G93899SO"},{"id":"A14","pred":"glycosmos_id","subj":"T14","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A15","pred":"glycosmos_id","subj":"T15","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A16","pred":"glycosmos_id","subj":"T16","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A17","pred":"glycosmos_id","subj":"T17","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A18","pred":"glycosmos_id","subj":"T18","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A19","pred":"glycosmos_id","subj":"T19","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A20","pred":"glycosmos_id","subj":"T20","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A21","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A22","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G93899SO"},{"id":"A23","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A24","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A25","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A26","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A27","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A28","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G15541SE"},{"id":"A29","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A30","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A31","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A32","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G93899SO"},{"id":"A33","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G93899SO"},{"id":"A34","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A35","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A36","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A37","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A38","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A39","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A40","pred":"image","subj":"T20","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    GlyCosmos15-GlycoEpitope

    {"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":92,"end":95},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":1377,"end":1380},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":1437,"end":1440},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0070"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0070"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}

    NCBITAXON

    {"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":22,"end":42},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":206,"end":226},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":856,"end":876},"obj":"OrganismTaxon"},{"id":"T4","span":{"begin":1128,"end":1144},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"197"},{"id":"A2","pred":"db_id","subj":"T2","obj":"197"},{"id":"A3","pred":"db_id","subj":"T3","obj":"197"},{"id":"A4","pred":"db_id","subj":"T4","obj":"562"}],"text":"Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.\nCstII from bacterium Campylobacter jejuni strain OH4384 has been previously characterized as a bifunctional sialyltransferase having both alpha2,3-sialyltransferase (GM3 oligosaccharide synthase) and alpha2,8-sialyltransferase (GD3 oligosaccharide synthase) activities which catalyze the transfer of N-acetylneuraminic acid (Neu5Ac) from cytidine 5'-monophosphate (CMP)-Neu5Ac to C-3' of the galactose in lactose and to C-8 of the Neu5Ac in 3'-sialyllactose, respectively (Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 277:327-337). We report here the characterization of a truncated CstII mutant (CstIIDelta32(I53S)) cloned from a synthetic gene whose codons are optimized for an Escherichia coli expression system. In addition to the alpha2,3- and alpha2,8-sialyltransferase activities reported before for the synthesis of GM3- and GD3-type oligosaccharides, respectively, the CstIIDelta32(I53S) has alpha2,8-sialyltransferase (GT3 oligosaccharide synthase) activity for the synthesis of GT3 oligosaccharide. It also has alpha2,8-sialidase (GD3 oligosaccharide sialidase) activity that catalyzes the specific cleavage of the alpha2,8-sialyl linkage of GD3-type oligosaccharides and alpha2,8-trans-sialidase (GD3 oligosaccharide trans-sialidase) activity that catalyzes the transfer of a sialic acid from a GD3 oligosaccharide to a different GM3 oligosaccharide (3'-sialyllactoside). The donor substrate specificity study of the CstIIDelta32(I53S) GD3 oligosaccharide synthase activity indicates that the enzyme is flexible in using different CMP-activated sialic acids and their analogs for the synthesis of GD3 oligosaccharides containing natural and nonnatural modifications at the terminal sialic acid."}